Mechanism for anti-AD effect of approved medicines
Project/Area Number |
24659037
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Single-year Grants |
Research Field |
Biological pharmacy
|
Research Institution | Keio University |
Principal Investigator |
|
Project Period (FY) |
2012-04-01 – 2014-03-31
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | アルツハイマー病 |
Research Abstract |
Transforming growth factor (TGF)-B1 stimulates this phagocytosis. We recently reported that the APP23 mouse model for AD showed fewer AD-related phenotypes when these animals were crossed with transgenic mice expressing heat shock protein (HSP) 70. We here examined the effect of geranylgeranylacetone, an inducer of HSP70 expression, on the AD-related phenotypes. Repeated oral administration of geranylgeranylacetone to APP23 mice for 9 months not only improved cognitive function but also decreased levels of AB, AB plaque deposition and synaptic loss. The treatment also up-regulated the expression of an AB-degrading enzyme and TGF-B1 but did not affect the maturation of APP and secretase activities. These outcomes were similar to those observed in APP23 mice genetically modified to overexpress HSP70. A single oral administration of geranylgeranylacetone significantly increased the level of HSP70 when AB was concomitantly injected directly into the hippocampus.
|
Report
(3 results)
Research Products
(27 results)
-
[Journal Article] Diclofenac protects cultured human corneal epithelial cells against hyperosmolarity and ameliorates corneal surface damage in a rat model of dry eye2014
Author(s)
Sawazaki, R., Ishihara, T., Usui, S., Hayashi, E., Tahara, K., Hoshino, T., Higuchi, A., Nakamura, S., Tsubota, K. and Mizushima, T.
-
Journal Title
Invest. Ophthalmol. Vis. Sci.
Volume: 55
Pages: 2547-2556
Related Report
-
[Journal Article] Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease2014
Author(s)
Tanaka, K., Kurotsu, S., Asano, T., Yamakawa, N., Kobayashi D., Yamashita, Y., Yamazaki, H., Ishihara, T., Watanabe, H., Maruyama, T., Suzuki, H. and Mizushima, T.
-
Journal Title
Sci. Rep.
Volume: 28
Pages: 4510-4510
Related Report
-
[Journal Article] Structure-activity relationship of celecoxib and rofecoxib for the membrane permeabilizing activity2014
Author(s)
Yamakawa, N., Suzuki, K., Yamashita, Y., Katsu, T., Hanaya, K., Shoji, M., Sugai, T. and Mizushima, T.
-
Journal Title
Bioorg. & Medic. Chem.
Volume: 22
Issue: 8
Pages: 2529-2534
DOI
Related Report
-
[Journal Article] Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease2013
Author(s)
Tanaka, K., Ishihara, T., Sugizaki, T., Kobayashi D., Yamashita, Y., Tahara, K., Yamakawa, N., Iijima, K., Mogushi, K., Tanaka, H., Sato, K., Suzuki, H. and Mizushima, T.
-
Journal Title
Nature Communications
Volume: 4
Pages: 2686-2686
Related Report
-
[Journal Article] Suppression of Alzheimer's disease-related phenotypes by geranygeranylacetone in mice2013
Author(s)
Hoshino, T., Suzuki, K., Matsushima, T., Yamakawa, N., Suzuki, T. and Mizushima, T
-
Journal Title
PLoS One
Volume: 8
Issue: 10
Pages: e76306-e76306
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Prostaglandin E1-encapsulated nanoparticles improve walking activity in an experimental rat model of intermittent claudication2013
Author(s)
Ishihara, T., Yamashita, Y., Takasaki, N., Yamamoto, S., Hayashi, E., Tahara, K., Takenaga, M., Yamakawa, N., Ishihara, T., Kasahara, T. and Mizushima, T.
-
Journal Title
J. Pharm. Pharmacol.
Volume: 65
Pages: 1187-1194
Related Report
-
-
[Journal Article] Comparison of pharmacokinetics between loxoprofen and its derivative with lower ulcerogenic activity, fluoro-loxoprofen2013
Author(s)
Yamakawa, N., Suemasu, S., Watanabe, H., Tahara, K., Tanaka, K., Okamoto, Y., Ohtsuka, M., Maruyama, T. and Mizushima, T.
-
Journal Title
Drug Metab. Pharmacokinet
Volume: 28
Pages: 118-124
NAID
Related Report
-
[Journal Article] Suppression of UV-induced wrinkle formation by induction of HSP70 expression in mice2013
Author(s)
Matsuda, M., Hoshino, T., Yamakawa, N., Tahara, K., Adachi, H., Sobue, G., Maji, D., Ihn, H. and Mizushima, T.
-
Journal Title
J. Invest. Dermatol.
Volume: 113
Issue: 4
Pages: 19-28
DOI
Related Report
-
-
[Journal Article] Suppression of Alzheimer's disease-related phenotypes by geranylgeranylacetone in mice.2013
Author(s)
Hoshino, T., Suzuki, K., Matsushima, T., Yamakawa, N., Suzuki, T. and Mizushima, T.
-
Journal Title
PLoS One
Volume: 8
Issue: 10
Pages: e76303-e76303
DOI
NAID
Related Report
Peer Reviewed
-
[Journal Article] Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease.2013
Author(s)
Tanaka, K., Ishihara, T., Sugizaki, T., Kobayashi D., Yamashita, Y., Tahara, K., Yamakawa, N., Iijima, K., Mogushi, K., Tanaka, H., Sato, K., Suzuki, H. and Mizushima, T.
-
Journal Title
Nature Communications
Volume: 4
Pages: 2686-2686
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] Synthesis and biological evaluation of derivatives of 2-{2-fluoro-4-[(2-oxocyclopentyl)methyl ]phenyl}propanoic acid : Non-steroidal anti-inflammatory drugs with low gastric ulcerogenic activity2012
Author(s)
Yamakawa, N., Suemasu, S., Okamoto, Y., Tanaka, K., Ishihara, T., Asano, T., Miyata, k., Ohtsuka, M. and Mizushima, T.
-
Journal Title
J. Med. Chem.
Volume: 55
Pages: 5143-5150
Related Report
-
-
-
[Journal Article] purification and characterization of hsp-inducers from eupatorium lindleyanum2012
Author(s)
Yamashita, Y., Ikeda, T., Matsuda, M., Maji, D., Hoshino, T. and Mizushima, T.
-
Journal Title
Biochem. Pharmacol.
Volume: 82
Pages: 909-922
Related Report
-
[Journal Article] Improvement of cognitive function in Alzheimer's disease model mice by genetic and pharmacological inhibition of the EP_4 receptor2012
Author(s)
Hoshino, T., Namba, T., Takehara, M., Murao, N., Sugimoto, Y., Narumiya, S., Matsushima, T., Suzuki, T. and Mizushima, T.
-
Journal Title
J. Neurochem.
Volume: 120
Pages: 795-805
Related Report
-
-
-
-
[Journal Article] Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities
Author(s)
Yamashita, Y., Tanaka, K., Asano, T., Yamakawa, N., Kobayashi D., Ishihara, T., Hanaya, K., Shoji, M., Sugai, T., Wada, M., Mashimo, T., Fukunishi, Y. and Mizushima, T.
-
Journal Title
Bioorg. & Medic. Chem.
Volume: (in press)
Related Report
-
[Journal Article] Ameliorative effect of mepenzolate bromide against pulmonary fibrosis
Author(s)
Kurotsu, S., Tanaka, K., Niino, T., Sugizaki, T., Azuma, A., Suzuki, H. and Mizushima, T.
-
Journal Title
J. Pharmacol. Exp. Ther.
Volume: (in press)
Related Report